VER Share PerformanceMore
|52 week high||33.500 20/02/17|
|52 week low||6.100 14/02/18|
|52 week change||-25.400 (-79.38%)|
|4 week volume||9,328,409 25/01/18|
Latest News« previous» nextMore
08/02/2018 - 16:35 RNS
RNS Number: 3715E Vernalis PLC 08 February 2018 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occu...
29/12/2017 - 07:00 RNS
RNS Number: 2499A Vernalis PLC 29 December 2017 TOTAL VOTING RIGHTS VERNALIS PLC (the "Company") 29 December 2017 Vernalis plc (LSE: VER) announces that the Company's total issued share capital at the date of this announcement is 526,819,624 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury. The to...
27/12/2017 - 16:40 RNS
RNS Number: 3917A Vernalis PLC 27 December 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percen...
27/12/2017 - 16:35 RNS
RNS Number: 3909A Vernalis PLC 27 December 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occ...
14/12/2017 - 13:15 RNS
RNS Number: 2977Z Vernalis PLC 14 December 2017 14 December 2017 LSE: VER Vernalis Results of Annual General Meeting Resolutions Vernalis plc (LSE: VER) announces that all resolutions proposed to shareholders at its Annual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votes received...
14/12/2017 - 08:49 StockMarketWire
Prescriptions of Vernalis' cough cold syrup Tuzistra XR continue to grow steadily, up 85% in the 22 weeks to 1 December. H...
14/12/2017 - 07:00 RNS
RNS Number: 2975Z Vernalis PLC 14 December 2017 14 December 2017 LSE: VER AGM Statement Tuzistra XR prescriptions continue to grow steadily, despite a reduction in narcotic prescribing Vernalis plc ("Vernalis" or the "Company") provides an update ahead of its Annual General Meeting ("AGM") being held today at 10.30 am at the offices of Covington & B...
13/12/2017 - 08:02 StockMarketWire
Vernalis has entered into a drug discovery collaboration with Daiichi Sankyo Company which will utilizing Vernalis' frag...
|Dividend yield||0 %|
Latest discussion posts More
“It's been a long one ( since mid Aug 2016 ) now . Whilst trend wise it's obviously only going one way I think we may find a bottom here . So my risk reward view of ...”▼
“Remember my post back in April ? Not many here since . Chart don't lie , it didn't then it isn't now . Though it may be basing . Or about to . In other words we ...”▼
“Recent RNS from Vernalis: "Total revenues are expected to be ahead of current market expectations, principally as a result of larger than expected research collaboration ...”▼
Codes & Symbols
|Symbols||VER, LSE:VER, VER.L, VER:LN, LON:VER, XLON:VER|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment